OS9 antibody (AA 232-413) (FITC)

Catalog No. ABIN7165901

Product Details anti-OS9 Antibody (FITC)

Target: OS9 (Osteosarcoma Amplified 9, Endoplasmic Reticulum Lectin (OS9))

Binding Specificity: AA 232-413

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This OS9 antibody is conjugated to FITC

Application: Please inquire

Cross-Reactivity: Human

Purification: >95%, Protein G purified

Immunogen: Recombinant Human Protein OS-9 protein (232-413AA)

Isotype: IgG

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C,-80 °C

Storage Comment: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Details for OS9

Target: OS9 (Osteosarcoma Amplified 9, Endoplasmic Reticulum Lectin (OS9))

Alternative Name: OS9 (OS9 Products)

Synonyms: OS-9 antibody, zgc:153838 antibody, 4632413K17Rik antibody, AU022351 antibody, Os-9 antibody, ERLEC2 antibody, OS9, endoplasmic reticulum lectin antibody, osteosarcoma amplified 9, endoplasmic reticulum lectin antibody, amplified in osteosarcoma antibody, OS9 antibody, os9 antibody, Os9 antibody

Background:

Background: Lectin which functions in endoplasmic reticulum (ER) quality control and ER-associated degradation (ERAD). May bind terminally misfolded non-glycosylated proteins as well as improperly folded glycoproteins, retain them in the ER, and possibly transfer them to the ubiquitination machinery and promote their degradation. Possible targets include TRPV4.

Aliases: Amplified in osteosarcoma 9 antibody, amplified in osteosarcoma antibody, ERLEC2 antibody, OS-9 antibody, Os9 antibody, OS9_HUMAN antibody, Osteosarcoma amplified 9 endoplasmic reticulum lectin antibody, Protein OS-9 antibody

UniProt: Q13438

Pathways: Maintenance of Protein Location, SARS-CoV-2 Protein Interactome